Sanofi: all 2,424 studies
Page 12 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid TumorsTerminatedNCT04242147Phase 1
- Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2TerminatedNCT04222985Phase 1
- Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of AgeCompletedNCT04210349Phase 3
- Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTCApproved for marketingNCT04204928
- Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male SubjectsCompletedNCT04171310Phase 1
- Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information UpdateCompletedNCT04170140
- KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic ImpairmentCompletedNCT04166942Phase 1
- Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of AgeCompletedNCT04144179Phase 1
- To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry DiseaseWithdrawnNCT04143958Phase 4
- Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsCompletedNCT04142086Phase 1
- Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in ColombiaActive, not recruitingNCT04113330
- A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)CompletedNCT04106544Not applicable
- A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)CompletedNCT04074187Phase 2/3
- Acne Vulgaris Related Microbiology and SerologyCompletedNCT04056598
- Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)CompletedNCT04045795Phase 1
- Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During PregnancyCompletedNCT04023708
- A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)TerminatedNCT04009681Phase 1/2
- Efficacy and Safety of Teicoplanin in CDADTerminatedNCT04003818Phase 4
- First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple MyelomaCompletedNCT04000282Phase 1
- Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Active, not recruitingNCT03992417
- Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BCompletedNCT03974113Phase 2/3
- A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in CanadaCompletedNCT03958799Phase 1
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy SubjectsCompletedNCT03955666Phase 1
- Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes MellitusCompletedNCT03916601Phase 1
- Sotagliflozin Multiple-dose Study in Healthy Chinese SubjectsCompletedNCT03909451Phase 1
- A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 DiabetesCompletedNCT03903016Phase 1
- A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsTerminatedNCT03871348Phase 1
- Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GISTApproved for marketingNCT03862885
- Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy AdultsCompletedNCT03858075Phase 1
- To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT03856619Phase 4
- Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT03854305Phase 2
- Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)CompletedNCT03849716
- A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03849599Phase 1
- Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)TerminatedNCT03816839Phase 1
- Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female SubjectsCompletedNCT03802487Phase 1
- Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal InsulinCompletedNCT03798080Phase 3
- Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)CompletedNCT03798054Phase 3
- Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveCompletedNCT03794336Phase 4
- Efficacy and Safety Study of Dupilumab in Patients With Persistent AsthmaCompletedNCT03782532Phase 3
- A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted ConditionsCompletedNCT03776227Phase 1
- LEMTRADA Pregnancy Registry in Multiple SclerosisCompletedNCT03774914
- Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03767543Phase 3
- Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC DeficiencyWithdrawnNCT03767270Phase 1/2
- Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in VietnamCompletedNCT03765437Phase 3
- Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without SulfonylureaTerminatedNCT03761134Phase 3
- Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of InsulinCompletedNCT03760991Phase 4
- Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and ExerciseTerminatedNCT03760965Phase 3
- Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral SclerosisTerminatedNCT03757351Phase 1
- Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IXCompletedNCT03754790Phase 3
- A Study of KY1005 in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03754309Phase 2
- Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple MyelomaCompletedNCT03733717Phase 1
- (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic MastocytosisActive, not recruitingNCT03731260Phase 2
- Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.CompletedNCT03703869
- Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One YearCompletedNCT03700242Phase 3
- Effect of Venglustat in Patients With Renal ImpairmentCompletedNCT03687554Phase 1
- Observational Evaluation of Atopic Dermatitis in Pediatric PatientsActive, not recruitingNCT03687359
- Evaluate Efficacy and Safety in Chinese Patients With Infantile-Onset Pompe Disease With One Year Alglucosidase Alfa TreatmentCompletedNCT03687333Phase 4
- Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female SubjectsCompletedNCT03681158Phase 1
- Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of PollutantsCompletedNCT03664882Phase 3
- DV2-HBV-27: Observational Pregnancy RegistryActive, not recruitingNCT03664648
- Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute PharyngitisCompletedNCT03583658Phase 3
- Passive Enhanced Safety Surveillance of Stamaril® Vaccine in KoreaCompletedNCT03541694
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)CompletedNCT03529123Phase 3
- Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep DisordersCompletedNCT03514732Phase 1
- Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3CompletedNCT03485677Phase 3
- Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) InfectionWithdrawnNCT03468829Phase 2
- A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent PatientsCompletedNCT03463135Phase 1
- Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate HypertensionCompletedNCT03462069Phase 2
- Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes MellitusCompletedNCT03462017Phase 1
- Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver DiseaseWithdrawnNCT03437720Phase 2
- Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus PatientsCompletedNCT03436498Phase 1
- Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza VaccineCompletedNCT03430089Phase 1
- A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension PeriodCompletedNCT03414736Phase 1
- A Drug-Drug Interaction Study Between Sotagliflozin and RamiprilCompletedNCT03414723Phase 1
- Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mLCompletedNCT03406000Phase 4
- Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza VaccineCompletedNCT03391193Phase 3
- A Drug to Drug Interaction Study of Sotagliflozin With HydrochlorothiazideCompletedNCT03387657Phase 1
- An Observational Study on Sarilumab-exposed PregnanciesCompletedNCT03378219
- A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese SubjectsCompletedNCT03376802Phase 1
- A Study of RG-012 in Subjects With Alport SyndromeCompletedNCT03373786Phase 1
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedNCT03359837Phase 4
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsCompletedNCT03350191Phase 1
- Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 YearsCompletedNCT03344029Phase 4
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLCCompletedNCT03326752Phase 1
- Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid TumorsCompletedNCT03324113Phase 1
- A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantActive, not recruitingNCT03319667Phase 3
- A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)CompletedNCT03317015Phase 3
- Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of DiabetesCompletedNCT03312478Phase 4
- Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy SubjectsCompletedNCT03310944Phase 1
- A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)CompletedNCT03275454Phase 1
- Sotagliflozin Bioequivalence StudyCompletedNCT03211195Phase 1
- A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes MellitusCompletedNCT03202875Phase 1
- An Observational Study on Teriflunomide-exposed PregnanciesCompletedNCT03198351
- A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid TumorsCompletedNCT03192345Phase 1
- A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy SubjectsCompletedNCT03174548Phase 1
- Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.CompletedNCT03172208Phase 1
- A Study of KY1005 in Healthy VolunteersCompletedNCT03161288Phase 1
- Zika Case Definition and Surveillance StudyCompletedNCT03158233
- Observational Study Describing the Immune Profile Induced By Pertussis VaccinesCompletedNCT03147898
- An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular EventCompletedNCT03099213Phase 4